Key facts
- This page summarizes Michelle A. Peluso's Form 4 filing for CVS HEALTH Corp (CVS).
- 2 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 04 Apr 2023, 16:35.
Michelle A. Peluso - 01 Apr 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- EVP and Co-President of Retail
- Issuer ticker
- CVS
- Reported as of
- 01 Apr 2023
- Net transaction value
- -$685,584
- SEC form
- 4
- Accepted by SEC
- 04 Apr 2023, 16:35:23 UTC
- Prior SEC filing
- 01 Mar 2023
- Next SEC filing
- 14 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michelle A. Peluso
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michelle A. Peluso filed Form 4 for CVS HEALTH Corp (CVS) on 04 Apr 2023.
Change
- Previous filing in this sequence was filed on 01 Mar 2023.
- Current net transaction value: -$685,584.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Tax liability
- Transaction value
- $7,304,599
- Shares
- -98,299
- Change %
- -44%
- Price
- $74.31
- Shares after
- 124,383
- Date
- 01 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
CVS
holding
Common Stock (Restricted)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 55,042
- Date
- 01 Apr 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
transaction
Derivative
Stock Option
Award
- Transaction value
- $6,619,015
- Shares
- +89,073
- Change %
- Price
- $74.31
- Shares after
- 89,073
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 89,073
- Exercise price
- $74.31
- Footnotes
- F4
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 86,386
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 86,386
- Exercise price
- $74.30
- Footnotes
- F2
CVS
holding
Derivative
Stock Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 57,172
- Date
- 01 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 57,172
- Exercise price
- $101.09
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a performance stock unit award.
Footnote F2
Option became exercisable in four equal annual installments, commencing 4/1/2022.
Footnote F3
Option became exercisable in four equal annual installments, commencing 4/1/2023.
Footnote F4
Option becomes exercisable in four equal annual installments, commencing 4/1/2024.